Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.09
Shares Outstanding179.9M
Average Volume (10 days)1.9M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.14)
Sales (TTM)$9.47
Book Value (MRQ)$17.35
Cash Flow (TTM)$0.27
Cash (MRQ)$4.20

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy15
 
Buy2
 
Hold3
 
Underperform0
 
Sell0
 

Recent Insider Transactions

G. Eric Davis
EVP, General Counsel
(3,309)
Dispose
Mar 20, 2020
Brian Mueller
SVP, Acting CFO
(414)
Dispose
Mar 20, 2020
Jeffrey R. Ajer
EVP, Chief Commercial Officer
(3,599)
Dispose
Mar 20, 2020
Henry J. Fuchs
President, Worldwide R&D
(5,836)
Dispose
Mar 20, 2020
Robert A. Baffi
President, Global Mfg/Tech Ops
(3,501)
Dispose
Mar 20, 2020

Recent SEC Filings

Insider Buy/Sell
Mar 26, 2020
Insider Buy/Sell
Mar 24, 2020
Insider Buy/Sell
Mar 24, 2020
Insider Buy/Sell
Mar 24, 2020
Insider Buy/Sell
Mar 24, 2020

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information